U.S. market Closed. Opens in 16 hours 44 minutes

CDTX | Cidara Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue63.91M64.29M49.57M12.07M20.91MN/AN/AN/AN/AN/AN/A
Cost of Revenue1.52M143.00K189.00K68.02M46.40MN/AN/AN/AN/AN/AN/A
Gross Profit62.38M64.14M49.38M-55.95M-25.49MN/AN/AN/AN/AN/AN/A
Operating Expenses86.86M94.01M91.83M83.92M62.64M63.28M55.72M48.44M32.31MN/AN/A
Selling, General & Admin18.33M18.49M18.74M15.90M16.24M14.14M12.90M12.74M8.84M3.31M272.00K
Research & Development68.53M75.52M73.09M68.02M46.40M49.14M42.82M35.70M23.48M6.71M810.00K
Other Operating ExpensesN/AN/AN/AN/AN/A-211.00KN/AN/AN/AN/AN/A
Operating Income-24.48M-29.72M-42.26M-71.85M-41.72M-63.28M-55.72M-48.44M-32.31M-10.02M-1.08M
Other Expenses / Income2.00M191.00K-212.00K-262.00K632.00K3.64M-7.00K271.00K120.00K-1.88M-262.00K
Before Tax Income-22.49M-29.53M-42.47M-72.11M-41.09M-59.02M-55.73M-48.16M-32.19M-11.89M-1.34M
Income Tax Expenses443.00K272.00K1.44M262.00K-1.01M4.27MN/AN/AN/AN/AN/A
Net Income-22.93M-29.80M-43.91M-72.37M-40.09M-59.02M-55.73M-48.16M-32.19M-11.89M-1.34M
Interest ExpensesN/A191.00K212.00K-262.00K221.00K629.00KN/AN/AN/AN/AN/A
Basic Shares Outstanding4.37M3.49M2.62M2.08M1.50M25.14M17.50M14.49M9.92M3.07M3.07M
Diluted Shares Outstanding4.37M3.49M2.62M2.08M1.50M25.87M17.50M14.49M9.92M3.07M3.07M
EBITDA-24.36M-29.72M-42.26M-71.62M-42.13M-67.14M-55.06M-47.70M-31.85M-8.23M-1.08M
EBITDA Margin-38.13%-46.23%-85.24%-593.52%-201.46%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-22.49M-29.34M-42.26M-72.37M-40.87M-54.12M-55.73M-48.16M-32.19M-11.89M-1.34M
EBIT Margin-35.19%-45.63%-85.24%-599.76%-195.41%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙